-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FUHzDRfydXyP49yE+k/PScpGRHr2k6qnyiEGShnYRdemrT8YZumdaDK2IJOWRJvw EDrgXw5JH2uybx36D07fEw== 0001424411-09-000013.txt : 20090213 0001424411-09-000013.hdr.sgml : 20090213 20090213135807 ACCESSION NUMBER: 0001424411-09-000013 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090211 FILED AS OF DATE: 20090213 DATE AS OF CHANGE: 20090213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murcray Scott CENTRAL INDEX KEY: 0001424842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50988 FILM NUMBER: 09601432 BUSINESS ADDRESS: BUSINESS PHONE: 408-360-7200 MAIL ADDRESS: STREET 1: 5799 FONTANOSO WAY CITY: SAN JOSE STATE: CA ZIP: 95138 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VNUS MEDICAL TECHNOLOGIES INC CENTRAL INDEX KEY: 0001040666 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943216535 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5799 FONTANOSO WAY CITY: SAN JOSE STATE: CA ZIP: 95138-1015 BUSINESS PHONE: 408-360-7200 MAIL ADDRESS: STREET 1: 5799 FONTANOSO WAY CITY: SAN JOSE STATE: CA ZIP: 95138-1015 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2009-02-11 0 0001040666 VNUS MEDICAL TECHNOLOGIES INC VNUS 0001424842 Murcray Scott C/O VNUS MEDICAL TECHNOLOGIES, INC. 5799 FONTANOSO WAY SAN JOSE CA 95138 0 1 0 0 Principal Accounting Officer Common Stock 2009-02-11 4 M 0 624 13.78 A 624 D Common Stock 2009-02-11 4 S 0 624 18.15 D 0 D Incentive Stock Option (right to buy) 13.78 2009-02-11 4 M 0 624 0 D 2017-07-02 Common Stock 624 3126 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. 25% of the shares subject to the option vest and become exercisable on July 2, 2008, and 1/36th of the shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on July 2, 2011. /s/ Cindee Van Vleck, Attorney-in-Fact for Scott Murcray 2009-02-13 -----END PRIVACY-ENHANCED MESSAGE-----